In the end, its all about perspective
What the Phase 2 Trial Arms Looked Like The table below records what was administered in that trial and the least-squares mean changes reported at 48 weeks a record of past research, not a protocol
The findings were controversial, though, since many were convinced that glucagon needed to be blocked, including DiMarchis close mentor, Gus Watanabe, a former executive at Lilly
BN is included here only for mechanistic completeness, as outlined in Chapter 1, because the current evidence base is extremely limited and does not support BN-specific clinical inference
Day 4: Plant-Based Motility (Fiber Focus) Goal: Increase soluble fiber intake gently
[DOI] [PMC free article] [PubMed] [Google Scholar] 350.Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI